Adverum Biotechnologies, Inc

(NASDAQ:ADVM)

Latest On Adverum Biotechnologies, Inc (ADVM):

Date/Time Type Description Signal Details
2023-05-12 05:45 ESTNewsAdverum Biotechnologies GAAP EPS of -$0.29N/A
2023-03-31 16:31 ESTNewsAdverum Biotechnologies GAAP EPS of -$0.33 beats by $0.03N/A
2022-11-11 05:31 ESTNewsAdverum Biotechnologies GAAP EPS of -$0.40 misses by $0.06N/A
2022-08-11 22:16 ESTNewsAdverum Biotechnologies GAAP EPS of -$0.44 misses by $0.10N/A
2022-07-08 00:31 ESTNewsAdverum gains 13% to reach three-month high after Truist upgradeN/A
2022-06-10 10:03 ESTNewsAdverum wet AMD candidate ADVM-022 shows long-term benefit after single injectionN/A
2022-05-13 06:31 ESTNewsAdverum Biotechnologies GAAP EPS of -$0.38 misses by $0.07N/A
2022-04-07 03:30 ESTNewsAdverum gets FDA feedback on mid-stage trial for Wet AMD candidateN/A
2022-03-29 21:15 ESTNewsAdverum Biotechnologies GAAP EPS of -$0.35 misses by $0.01N/A
2022-02-07 17:00 ESTNewsAdverum Biotechnologies names new CMON/A
2022-01-03 15:46 ESTNewsAdverum granted FDA’s Orphan Drug Designation for treatment targeting color blindnessN/A
2021-11-05 00:15 ESTNewsAdverum Biotechnologies EPS misses by $0.01N/A
2021-10-02 05:31 ESTNewsAdverum posts promising two-year data for one-time injection in Wet AMDN/A
2021-10-02 05:31 ESTNewsADVM, SCPS, HX and NUVL among after hours moversN/A
2021-08-05 21:02 ESTNewsAdverum Biotechnologies EPS misses by $0.07N/A
2021-07-23 14:16 ESTNewsAdverum plunges as analysts turn bearish citing setback for diabetic macular edema drugN/A
2021-07-22 18:17 ESTNewsAdverum scraps development plans for ADVM-022 to treat diabetic macular edemaN/A
2021-07-20 17:43 ESTNewsAdverum President/CFO resigns, replacement namedN/A
2021-05-07 02:46 ESTNewsAdverum Biotechnologies EPS beats by $0.09, beats on revenueN/A
2021-05-06 06:34 ESTNewsAdverum Biotechnologies: An Uncertain Path ForwardN/A
2021-05-03 17:04 ESTNewsAdverum Bio presents long-term data from ADVM-022 trial in wet AMDN/A
2021-05-03 17:04 ESTNewsAdverum Biotechnologies: One Adverse Event Too ManyN/A
2021-05-03 17:03 ESTNewsTenet reinstated buy at Goldman Sachs, Adverum downgraded; in today’s healthcare analyst actionN/A
2021-04-30 05:05 ESTNewsAs Adverum plunges 62%, major shareholder calls for board changes (updated)N/A
2021-04-29 06:17 ESTNewsAdverum Biotechnologies provides update on ADVM-022 diabetic macular edema trialN/A
2021-03-26 04:01 ESTNewsAdverum Biotechnologies perks up after insider buyingN/A
2021-03-08 15:02 ESTAnalyst RatingThe Analyst Target Price has decreased from $25 to $24.89.Neutral
2021-03-04 15:02 ESTAnalyst RatingThe Analyst Target Price has decreased from $25.25 to $25.Neutral
2021-03-03 21:16 ESTNewsAdverum Biotechnologies, Inc. 2020 Q4 - Results - Earnings Call PresentationN/A
2021-03-03 15:02 ESTEarnings EstimateAn EPS average of -$1.82 is estimated for the 2022 year.Sell
2021-03-03 15:02 ESTEarnings EstimateAn EPS average of -$0.38 is estimated for the quarter ending on June 30, 2021.Buy
2021-03-03 15:02 ESTAnalyst RatingThe Analyst Target Price has decreased from $25.88 to $25.25.Neutral
2021-03-02 23:02 ESTFinancialsCompany financials have been released.Neutral
2021-03-02 07:16 ESTNewsAdverum Biotechnologies EPS misses by $0.06N/A
2021-03-02 07:16 ESTNewsAdverum Biotechnologies, Inc's (ADVM) CEO Laurent Fischer on Q4 2020 Results - Earnings Call TranscriptN/A
2021-02-19 04:46 ESTNewsAdverum Biotechnologies names new business chiefN/A
2021-02-12 11:02 ESTAnalyst RatingThe Analyst Target Price has increased from $25.22 to $25.88.Buy
2021-02-02 21:02 ESTNewsAdverum highlights preclinical long-term safety data on ADVM-022 IVT gene therapyN/A
2021-01-21 05:17 ESTNewsAdverum jumps 16% after insider transactionsN/A
2021-01-11 00:01 ESTNewsAdverum In Wet AMD And Diabetic Macular Edema: Playing In A Differentiated MarketN/A
2021-01-07 22:16 ESTNewsAdverum to invest $80M in new gene therapy manufacturing facilityN/A
2020-12-29 11:02 ESTAnalyst RatingThe Analyst Target Price has decreased from $26.75 to $25.22.Neutral
2020-12-13 03:03 ESTFinancialsCompany financials have been released.Neutral
2020-11-25 11:04 ESTFinancialsCompany financials have been released.Neutral
2020-11-16 15:01 ESTNewsAdverum ticks lower on underwhelming data from gene therapy in wet-AMDN/A
2020-11-10 19:03 ESTAnalyst RatingThe Analyst Target Price has decreased from $27 to $26.75.Neutral
2020-11-09 03:03 ESTFinancialsCompany financials have been released.Neutral
2020-11-08 23:02 ESTAnalyst RatingThe Analyst Target Price has decreased from $27.38 to $27.Neutral
2020-11-06 11:02 ESTEarnings EstimateAn EPS average of -$0.36 is estimated for the quarter ending on March 31, 2021.Sell
2020-11-06 01:16 ESTNewsAdverum Biotechnologies EPS beats by $0.04N/A

About Adverum Biotechnologies, Inc (ADVM):

Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal diseases, including wet age-related macular degeneration and diabetic macular edema. Adverum Biotechnologies, Inc. has license and collaboration agreements with University of California; Cornell University; GenSight; Lexeo; and Virovek. The company was formerly known as Avalanche Biotechnologies, Inc. and changed its name to Adverum Biotechnologies, Inc. in May 2016. Adverum Biotechnologies, Inc. was incorporated in 2006 and is headquartered in Redwood City, California.

ADVM Quotes by TradingView

See Advanced Chart

General

  • Name Adverum Biotechnologies, Inc
  • Symbol ADVM
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 167
  • Fiscal Year EndDecember
  • IPO Date2014-07-31
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://www.adverum.com
View More

Valuation

  • Price/Sales (Trailing 12 Mt.) 3419.85
  • Price/Book (Most Recent Quarter) 2.73
  • Enterprise Value Revenue 3700.64
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$1.68
  • Next Year EPS Estimate -$2.00
  • Next Quarter EPS Estimate -$0.31
  • Return on Assets -21%
  • Return on Equity -39%
  • Earnings Per Share -$1.05
  • Revenue Per Share $0
  • Gross Profit -73309000
  • Quarterly Earnings Growth -70%
View More

Highlights

  • Market Capitalization 1.01 billion
  • EBITDA -59744000
  • Analyst Target Price $24.89
  • Book Value Per Share $4.45
View More

Share Statistics

  • Shares Outstanding 97.8 million
  • Shares Float 61.93 million
  • % Held by Insiders 75%
  • % Held by Institutions 96.25%
  • Shares Short 10.05 million
  • Shares Short Prior Month 9.46 million
  • Short Ratio 14.75
  • Short % of Float 11%
  • Short % of Shares Outstanding 10%
View More

Technicals

  • Beta 1.49
  • 52 Week High $26.98
  • 52 Week Low $8.27
  • 50 Day Moving Average 12.45
  • 200 Day Moving Average 12.28
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Adverum Biotechnologies, Inc (ADVM) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Adverum Biotechnologies, Inc (ADVM) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-03-01$N/A-$0.39-$0.33-18.51%
2020-09-302020-11-05$N/A-$0.31-$0.3511.43%
2020-06-302020-08-10$N/A-$0.36-$0.29-23.58%
2020-03-312020-05-28$N/A-$0.31-$0.27-14.35%
2019-12-312020-03-12$N/A-$0.29-$0.302.26%
2019-09-302019-11-07$250000-$0.25-$0.265.41%
2019-06-302019-08-08$N/A-$0.23-$0.2713.21%
2019-03-312019-05-08$N/A-$0.23-$0.2714.18%
2018-12-312019-03-06$70000-$0.25-$0.2912.59%
2018-09-302018-11-08$833000-$0.34-$0.30-13.98%
2018-06-302018-08-08$493000-$0.30-$0.312.18%
2018-03-312018-05-09$216000-$0.30-$0.29-3.45%
2017-12-312018-03-06$461000-$0.32-$0.346.79%
2017-09-302017-11-08$463000-$0.32-$0.29-10.34%
2017-06-302017-08-08$463000-$0.27-$0.3316.92%
2017-03-312017-05-09$462000-$0.38-$0.26-46.15%
2016-12-312017-03-06$488000-$0.54-$0.30-78.04%
2016-09-302016-11-08$395000-$0.35-$0.29-19.33%
2016-06-302016-08-09$307000-$1.76-$0.33-441.54%
2016-03-312016-05-06$265000-$0.57-$0.29-96.55%
2015-12-312016-03-03$960000-$0.55-$0.40-36.37%
2015-09-302015-11-09$953000-$0.55-$0.42-30.95%
2015-06-302015-08-13$203000-$0.38-$0.392.56%
2015-03-312015-05-13$203000-$0.38-$0.405%
2014-12-312015-03-05$203000-$0.46-$0.29-58.62%
2014-09-302014-11-12$204000-$0.50-$0.21-138.1%
2014-06-302014-09-11$135000-$2.27

Adverum Biotechnologies, Inc (ADVM) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Adverum Biotechnologies, Inc (ADVM) Chart:

Adverum Biotechnologies, Inc (ADVM) News:

Below you will find a list of latest news for Adverum Biotechnologies, Inc (ADVM) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Adverum Biotechnologies, Inc (ADVM) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2025-04-1710CALL0 0682.25TRUE00
2025-04-1720CALL0 0657.91TRUE00
2025-04-1731.6CALL0 4499.55TRUE00
2025-04-1741.15CALL0 2115.31TRUE00
2025-04-1750.9CALL0 12124.91FALSE00
2025-04-1760.2CALL0 39149.02FALSE00
2025-04-1770CALL0 0192.03FALSE00
2025-04-1780CALL0 0178.48FALSE00
2025-04-1790.1CALL0 2811.2FALSE00
2025-04-17100.05CALL0 1487.9FALSE00
2025-04-1710PUT0 0695.87FALSE00
2025-04-1720PUT0 0398.37FALSE00
2025-04-1730.05PUT0 50141.51FALSE00
2025-04-1740PUT0 089.93FALSE00
2025-04-1750PUT0 0135.75TRUE00
2025-04-1761PUT0 2274.56TRUE00
2025-04-1770PUT0 0419.24TRUE00
2025-04-1780PUT0 0188.54TRUE00
2025-04-1790PUT0 0315.53TRUE00
2025-04-17100PUT0 0167.32TRUE00
2025-05-1610CALL0 0427.81TRUE00
2025-05-1620CALL0 0243.15TRUE00
2025-05-1630CALL0 0159.37TRUE00
2025-05-1641.36CALL0 0116.08TRUE00
2025-05-1650CALL0 0175.73FALSE00
2025-05-1660CALL0 097.53FALSE00
2025-05-1670CALL0 0125.04FALSE00
2025-05-1680.32CALL0 10136.32FALSE00
2025-05-1690CALL0 0159.3FALSE00
2025-05-16100CALL0 0179.88FALSE00
2025-05-1610PUT0 0438.75FALSE00
2025-05-1620PUT0 0251.41FALSE00
2025-05-1630PUT0 0117.57FALSE00
2025-05-1640PUT0 0143.39FALSE00
2025-05-1650.65PUT0 586.82TRUE00
2025-05-1660PUT0 0193.47TRUE00
2025-05-1670PUT0 0190.49TRUE00
2025-05-1680PUT0 0173.68TRUE00
2025-05-1690PUT0 0140.14TRUE00
2025-05-16100PUT0 0139.28TRUE00
2025-06-2010CALL0 0350.89TRUE00
2025-06-2023.1CALL0 3212.26TRUE00
2025-06-2030CALL0 0228.3TRUE00
2025-06-2041.35CALL309 3123.64TRUE1.350
2025-06-2051.1CALL0 9112.58FALSE00
2025-06-2060.67CALL0 332121.89FALSE00
2025-06-2070.94CALL0 33150.94FALSE00
2025-06-2080.38CALL0 14114.8FALSE00
2025-06-2090.35CALL0 8387.21FALSE00
2025-06-20102.85CALL0 27136.34FALSE00
2025-06-20112.45CALL0 13146.47FALSE00
2025-06-20120CALL0 0155.43FALSE00
2025-06-20130CALL0 0163.46FALSE00
2025-06-20140CALL0 0209.06FALSE00
2025-06-20150CALL0 0205.48FALSE00
2025-06-2010PUT0 0470.48FALSE00
2025-06-2020PUT0 0191.9FALSE00
2025-06-2030.25PUT10 0117.26FALSE0.250
2025-06-2040.85PUT0 6190.59FALSE00
2025-06-2051.4PUT434 5136.22TRUE1.40
2025-06-2060PUT0 0145.98TRUE00
2025-06-2070PUT0 0173.05TRUE00
2025-06-2080PUT0 0165.98TRUE00
2025-06-2090PUT0 0156.61TRUE00
2025-06-20105.6PUT0 10148.41TRUE00
2025-06-20110PUT0 0142.71TRUE00
2025-06-20120PUT0 0142.17TRUE00
2025-06-20130PUT0 0286.38TRUE00
2025-06-20140PUT0 0186.72TRUE00
2025-06-20150PUT0 0165.71TRUE00
2025-09-1910CALL0 0221.41TRUE00
2025-09-1920CALL0 0181.94TRUE00
2025-09-1930CALL0 0214TRUE00
2025-09-1940CALL0 097.4TRUE00
2025-09-1951.28CALL0 10221.64FALSE00
2025-09-1960CALL0 0152.77FALSE00
2025-09-1971.1CALL0 2244.73FALSE00
2025-09-1980.6CALL0 15111.84FALSE00
2025-09-1990.6CALL0 2097.97FALSE00
2025-09-19100CALL0 0108.83FALSE00
2025-09-1910PUT0 0327.37FALSE00
2025-09-1920PUT0 0133.79FALSE00
2025-09-1930.62PUT0 1161.11FALSE00
2025-09-1940.85PUT10 5100.7FALSE0.850
2025-09-1951.8PUT0 10159.69TRUE00
2025-09-1960PUT0 0155.9TRUE00
2025-09-1970PUT0 0152.74TRUE00
2025-09-1980PUT0 0134.88TRUE00
2025-09-1990PUT0 0142.45TRUE00
2025-09-19100PUT0 0140.01TRUE00

Latest ADVM Trades:

Date Shares Price
Jun 13, 2022 7:58 PM EST800$0.952
Jun 13, 2022 7:58 PM EST100$0.952
Jun 13, 2022 7:59 PM EST13$0.951
Jun 13, 2022 7:59 PM EST8$0.951
Jun 13, 2022 7:59 PM EST33$0.951

Adverum Biotechnologies, Inc (ADVM) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1501756/000119312520182655/0001193125-20-182655-index.htm
2019-02-08SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1501756/000021545719006772/0000215457-19-006772-index.htm
2020-02-05SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1501756/000083423720004851/0000834237-20-004851-index.htm
2019-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1501756/000090266419000919/0000902664-19-000919-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1501756/000090266419001088/0000902664-19-001088-index.htm
2019-05-30SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1501756/000090266419002558/0000902664-19-002558-index.htm
2020-02-12SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1501756/000090266420000939/0000902664-20-000939-index.htm
2020-02-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1501756/000090266420001119/0000902664-20-001119-index.htm
2019-03-21SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1501756/000101359419000276/0001013594-19-000276-index.htm
2019-05-03SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1501756/000101359419000364/0001013594-19-000364-index.htm
2020-08-20SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1501756/000101359420000655/0001013594-20-000655-index.htm
2019-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1501756/000103738919000142/0001037389-19-000142-index.htm
2020-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1501756/000103738920000303/0001037389-20-000303-index.htm
2020-02-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1501756/000117266120000647/0001172661-20-000647-index.htm
2018-03-23S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1501756/000119312518094349/0001193125-18-094349-index.htm
2018-04-20DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1501756/000119312518124872/0001193125-18-124872-index.htm
2018-04-20DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1501756/000119312518124877/0001193125-18-124877-index.htm
2018-05-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1501756/000119312518150878/0001193125-18-150878-index.htm
2018-05-09DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1501756/000119312518157646/0001193125-18-157646-index.htm
2018-06-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1501756/000119312518181838/0001193125-18-181838-index.htm
2018-06-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1501756/000119312518194580/0001193125-18-194580-index.htm
2018-07-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1501756/000119312518211393/0001193125-18-211393-index.htm
2018-10-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1501756/000119312518301082/0001193125-18-301082-index.htm
2018-10-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1501756/000119312518306392/0001193125-18-306392-index.htm
2019-03-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1501756/000119312519060892/0001193125-19-060892-index.htm
2019-03-07S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1501756/000119312519067443/0001193125-19-067443-index.htm
2019-03-12S-8 POSSecurities to be offered to employees in employee benefit plans, post-effective amendmentshttps://www.sec.gov/Archives/edgar/data/1501756/000119312519071950/0001193125-19-071950-index.htm
2019-04-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1501756/000119312519117153/0001193125-19-117153-index.htm
2019-04-3010-K/AAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1501756/000119312519126512/0001193125-19-126512-index.htm
2019-05-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1501756/000119312519135105/0001193125-19-135105-index.htm
2019-06-17DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1501756/000119312519174714/0001193125-19-174714-index.htm
2019-06-17DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1501756/000119312519174720/0001193125-19-174720-index.htm
2019-07-318-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1501756/000119312519208871/0001193125-19-208871-index.htm
2019-08-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1501756/000119312519210860/0001193125-19-210860-index.htm
2019-08-08S-3ASRAutomatic shelf registration statement of securities of well-known seasoned issuershttps://www.sec.gov/Archives/edgar/data/1501756/000119312519216895/0001193125-19-216895-index.htm
2019-08-08S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1501756/000119312519216899/0001193125-19-216899-index.htm
2019-09-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1501756/000119312519240084/0001193125-19-240084-index.htm
2019-09-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1501756/000119312519243345/0001193125-19-243345-index.htm
2019-12-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1501756/000119312519314138/0001193125-19-314138-index.htm
2020-02-10424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1501756/000119312520029953/0001193125-20-029953-index.htm
2020-02-12424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1501756/000119312520033298/0001193125-20-033298-index.htm
2020-02-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1501756/000119312520033345/0001193125-20-033345-index.htm
2020-03-12S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1501756/000119312520071731/0001193125-20-071731-index.htm
2020-04-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1501756/000119312520112176/0001193125-20-112176-index.htm
2020-04-28DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1501756/000119312520123125/0001193125-20-123125-index.htm
2020-04-28DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1501756/000119312520123159/0001193125-20-123159-index.htm
2020-06-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1501756/000119312520169353/0001193125-20-169353-index.htm
2020-06-19DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1501756/000119312520174007/0001193125-20-174007-index.htm
2020-06-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1501756/000119312520182655/0001193125-20-182655-index.htm
2020-08-10S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1501756/000119312520215063/0001193125-20-215063-index.htm
2020-08-12424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1501756/000119312520216586/0001193125-20-216586-index.htm
2020-08-13424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1501756/000119312520219223/0001193125-20-219223-index.htm
2020-08-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1501756/000119312520219248/0001193125-20-219248-index.htm
2018-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919118038052/0001209191-18-038052-index.htm
2018-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919118038054/0001209191-18-038054-index.htm
2018-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919118038055/0001209191-18-038055-index.htm
2018-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919118038058/0001209191-18-038058-index.htm
2018-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919118038066/0001209191-18-038066-index.htm
2018-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919118038086/0001209191-18-038086-index.htm
2018-06-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919118038333/0001209191-18-038333-index.htm
2018-06-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919118038335/0001209191-18-038335-index.htm
2018-06-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919118038336/0001209191-18-038336-index.htm
2018-10-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919118055834/0001209191-18-055834-index.htm
2019-02-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919119011063/0001209191-19-011063-index.htm
2019-02-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919119011066/0001209191-19-011066-index.htm
2019-02-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919119011069/0001209191-19-011069-index.htm
2019-04-023Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919119022581/0001209191-19-022581-index.htm
2019-04-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919119022603/0001209191-19-022603-index.htm
2019-04-253Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919119026003/0001209191-19-026003-index.htm
2019-04-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919119026004/0001209191-19-026004-index.htm
2019-05-033Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919119027386/0001209191-19-027386-index.htm
2019-05-033Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919119027389/0001209191-19-027389-index.htm
2019-05-033Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919119027391/0001209191-19-027391-index.htm
2019-05-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919119027395/0001209191-19-027395-index.htm
2019-05-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919119027396/0001209191-19-027396-index.htm
2019-05-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919119027398/0001209191-19-027398-index.htm
2019-05-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919119027832/0001209191-19-027832-index.htm
2019-08-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919119044245/0001209191-19-044245-index.htm
2019-08-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919119044247/0001209191-19-044247-index.htm
2019-08-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919119044249/0001209191-19-044249-index.htm
2019-08-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919119044251/0001209191-19-044251-index.htm
2019-08-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919119044254/0001209191-19-044254-index.htm
2019-08-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919119044256/0001209191-19-044256-index.htm
2019-08-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919119044258/0001209191-19-044258-index.htm
2019-08-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919119044260/0001209191-19-044260-index.htm
2019-08-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919119046306/0001209191-19-046306-index.htm
2019-08-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919119046311/0001209191-19-046311-index.htm
2019-08-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919119046313/0001209191-19-046313-index.htm
2019-10-254/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919119054092/0001209191-19-054092-index.htm
2019-11-013Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919119054741/0001209191-19-054741-index.htm
2019-11-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919119054742/0001209191-19-054742-index.htm
2019-12-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919119061950/0001209191-19-061950-index.htm
2020-01-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919120001014/0001209191-20-001014-index.htm
2020-02-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919120007754/0001209191-20-007754-index.htm
2020-02-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919120007755/0001209191-20-007755-index.htm
2020-02-104/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919120007756/0001209191-20-007756-index.htm
2020-02-104/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919120007757/0001209191-20-007757-index.htm
2020-02-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919120007758/0001209191-20-007758-index.htm
2020-02-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919120007759/0001209191-20-007759-index.htm
2020-02-144/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919120009846/0001209191-20-009846-index.htm
2020-02-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919120009847/0001209191-20-009847-index.htm
2020-02-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919120009848/0001209191-20-009848-index.htm
2020-02-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919120011155/0001209191-20-011155-index.htm
2020-02-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919120011783/0001209191-20-011783-index.htm
2020-02-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919120011785/0001209191-20-011785-index.htm
2020-02-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919120011787/0001209191-20-011787-index.htm
2020-02-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919120011789/0001209191-20-011789-index.htm
2020-02-253Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919120012797/0001209191-20-012797-index.htm
2020-02-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919120012798/0001209191-20-012798-index.htm
2020-03-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919120020107/0001209191-20-020107-index.htm
2020-03-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919120021159/0001209191-20-021159-index.htm
2020-04-203Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919120025153/0001209191-20-025153-index.htm
2020-04-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919120025154/0001209191-20-025154-index.htm
2020-05-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919120027287/0001209191-20-027287-index.htm
2020-05-084/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919120028067/0001209191-20-028067-index.htm
2020-05-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919120028070/0001209191-20-028070-index.htm
2020-05-204/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919120031045/0001209191-20-031045-index.htm
2020-05-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919120031047/0001209191-20-031047-index.htm
2020-05-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919120031872/0001209191-20-031872-index.htm
2020-06-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919120037330/0001209191-20-037330-index.htm
2020-06-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919120037335/0001209191-20-037335-index.htm
2020-06-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919120037339/0001209191-20-037339-index.htm
2020-06-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919120037369/0001209191-20-037369-index.htm
2020-06-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919120037769/0001209191-20-037769-index.htm
2020-06-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919120038635/0001209191-20-038635-index.htm
2020-06-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919120038958/0001209191-20-038958-index.htm
2020-06-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919120038959/0001209191-20-038959-index.htm
2020-06-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919120038960/0001209191-20-038960-index.htm
2020-06-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919120038962/0001209191-20-038962-index.htm
2020-06-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919120038963/0001209191-20-038963-index.htm
2020-06-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919120038964/0001209191-20-038964-index.htm
2020-06-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919120038966/0001209191-20-038966-index.htm
2020-06-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919120038967/0001209191-20-038967-index.htm
2020-07-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919120043426/0001209191-20-043426-index.htm
2020-08-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919120047622/0001209191-20-047622-index.htm
2020-08-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919120047624/0001209191-20-047624-index.htm
2018-11-16SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1501756/000149315218016327/0001493152-18-016327-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1501756/000149315219001941/0001493152-19-001941-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1501756/000149315220002379/0001493152-20-002379-index.htm
2018-05-0910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1501756/000156459018012437/0001564590-18-012437-index.htm
2018-08-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1501756/000156459018020510/0001564590-18-020510-index.htm
2018-11-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1501756/000156459018028654/0001564590-18-028654-index.htm
2019-03-0610-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1501756/000156459019006536/0001564590-19-006536-index.htm
2019-05-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1501756/000156459019017203/0001564590-19-017203-index.htm
2019-08-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1501756/000156459019030765/0001564590-19-030765-index.htm
2019-11-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1501756/000156459019041787/0001564590-19-041787-index.htm
2020-03-1210-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1501756/000156459020010503/0001564590-20-010503-index.htm
2020-05-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1501756/000162828020007251/0001628280-20-007251-index.htm
2020-05-2810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1501756/000162828020008534/0001628280-20-008534-index.htm
2020-08-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1501756/000162828020012330/0001628280-20-012330-index.htm
2020-08-1010-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1501756/000162828020012332/0001628280-20-012332-index.htm
2020-11-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1501756/000162828020015738/0001628280-20-015738-index.htm
2020-11-0510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1501756/000162828020015761/0001628280-20-015761-index.htm
2018-04-16CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1501756/999999999718004871/9999999997-18-004871-index.htm
2019-03-19CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1501756/999999999719001422/9999999997-19-001422-index.htm
2020-06-24CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1501756/999999999720003738/9999999997-20-003738-index.htm

Adverum Biotechnologies, Inc (ADVM) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Adverum Biotechnologies, Inc (ADVM). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 75%
Institutional Ownership: 9625%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2020-08-17Peter SoparkarChief Legal OfficerBuy7,692.0013.0099,996.0010,692.00https://www.sec.gov/Archives/edgar/data/1501756/000120919120047624/0001209191-20-047624-index.htm
2020-06-16LEONE D PATTERSONPresidentSell13,171.0024.68325,060.28110,488.00https://www.sec.gov/Archives/edgar/data/1501756/000120919120037369/0001209191-20-037369-index.htm
2018-06-15Jennifer C. ChengGeneral CounselBuy11,150.00118,863.00https://www.sec.gov/Archives/edgar/data/1501756/000120919118038335/0001209191-18-038335-index.htm
2020-03-20LEONE D PATTERSONCEO, President and DirectorSell39,526.0010.17401,908.27123,429.00https://www.sec.gov/Archives/edgar/data/1501756/000120919120021159/0001209191-20-021159-index.htm
2020-05-06LEONE D PATTERSONCEO, President and DirectorSell20,000.0020.02400,400.00123,659.00https://www.sec.gov/Archives/edgar/data/1501756/000120919120028070/0001209191-20-028070-index.htm
2020-03-17LEONE D PATTERSONCEO, President and DirectorSell474.0010.024,749.24138,531.00https://www.sec.gov/Archives/edgar/data/1501756/000120919120020107/0001209191-20-020107-index.htm
2020-05-06LEONE D PATTERSONCEO, President and DirectorBuy20,000.003.4468,800.00143,659.00https://www.sec.gov/Archives/edgar/data/1501756/000120919120028070/0001209191-20-028070-index.htm
2020-03-20LEONE D PATTERSONCEO, President and DirectorBuy24,424.003.4484,018.56162,955.00https://www.sec.gov/Archives/edgar/data/1501756/000120919120021159/0001209191-20-021159-index.htm
2019-05-06James Paul ScopaDirectorBuy20,000.006.71134,200.0020,000.00https://www.sec.gov/Archives/edgar/data/1501756/000120919119027832/0001209191-19-027832-index.htm
2019-12-23LEONE D PATTERSONCEO, President and DirectorSell40,000.0010.72428,800.00228,496.00https://www.sec.gov/Archives/edgar/data/1501756/000120919119061950/0001209191-19-061950-index.htm
2020-02-12Mehdi GasmiDirectorSell10,000.0015.07150,690.00258,979.00https://www.sec.gov/Archives/edgar/data/1501756/000120919120009847/0001209191-20-009847-index.htm
2020-02-18Mehdi GasmiDirectorSell5,000.0016.2381,156.00258,979.00https://www.sec.gov/Archives/edgar/data/1501756/000120919120011155/0001209191-20-011155-index.htm
2020-02-18Mehdi GasmiDirectorBuy5,000.004.8024,000.00263,979.00https://www.sec.gov/Archives/edgar/data/1501756/000120919120011155/0001209191-20-011155-index.htm
2018-06-15LEONE D PATTERSONSVP, CFO, Interim Pres and CEOBuy88,496.00268,496.00https://www.sec.gov/Archives/edgar/data/1501756/000120919118038333/0001209191-18-038333-index.htm
2020-02-12Mehdi GasmiDirectorBuy10,000.004.8048,000.00268,979.00https://www.sec.gov/Archives/edgar/data/1501756/000120919120009847/0001209191-20-009847-index.htm
2020-05-05Mehdi GasmiDirectorSell10,000.0016.26162,573.00274,442.00https://www.sec.gov/Archives/edgar/data/1501756/000120919120031047/0001209191-20-031047-index.htm
2020-05-06Mehdi GasmiDirectorSell25,000.0020.03500,667.50274,442.00https://www.sec.gov/Archives/edgar/data/1501756/000120919120031047/0001209191-20-031047-index.htm
2020-05-18Mehdi GasmiDirectorSell300.0019.035,709.00274,442.00https://www.sec.gov/Archives/edgar/data/1501756/000120919120031047/0001209191-20-031047-index.htm
2020-05-20Mehdi GasmiDirectorSell1,401.0020.0128,029.95274,442.00https://www.sec.gov/Archives/edgar/data/1501756/000120919120031872/0001209191-20-031872-index.htm
2020-05-21Mehdi GasmiDirectorSell3,599.0020.0272,048.02274,442.00https://www.sec.gov/Archives/edgar/data/1501756/000120919120031872/0001209191-20-031872-index.htm
2020-06-15Mehdi GasmiDirectorSell159.0023.593,751.18274,442.00https://www.sec.gov/Archives/edgar/data/1501756/000120919120037339/0001209191-20-037339-index.htm
2020-06-17Mehdi GasmiDirectorSell268.0025.016,702.71274,442.00https://www.sec.gov/Archives/edgar/data/1501756/000120919120037769/0001209191-20-037769-index.htm
2020-06-18Mehdi GasmiDirectorSell11,127.0025.01278,328.55274,442.00https://www.sec.gov/Archives/edgar/data/1501756/000120919120037769/0001209191-20-037769-index.htm
2020-06-22Mehdi GasmiDirectorSell23,605.0025.06591,616.84274,442.00https://www.sec.gov/Archives/edgar/data/1501756/000120919120038635/0001209191-20-038635-index.htm
2020-07-20Mehdi GasmiDirectorSell5,000.0017.6087,978.00274,442.00https://www.sec.gov/Archives/edgar/data/1501756/000120919120043426/0001209191-20-043426-index.htm
2020-06-15Mehdi GasmiDirectorSell3,425.0023.0078,786.65274,601.00https://www.sec.gov/Archives/edgar/data/1501756/000120919120037339/0001209191-20-037339-index.htm
2020-06-17Mehdi GasmiDirectorBuy268.004.801,286.40274,710.00https://www.sec.gov/Archives/edgar/data/1501756/000120919120037769/0001209191-20-037769-index.htm
2020-05-18Mehdi GasmiDirectorSell4,700.0018.1185,124.05274,742.00https://www.sec.gov/Archives/edgar/data/1501756/000120919120031047/0001209191-20-031047-index.htm
2020-05-20Mehdi GasmiDirectorBuy1,401.004.806,724.80275,843.00https://www.sec.gov/Archives/edgar/data/1501756/000120919120031872/0001209191-20-031872-index.htm
2020-06-15Mehdi GasmiDirectorSell1,416.0021.9331,047.07278,026.00https://www.sec.gov/Archives/edgar/data/1501756/000120919120037339/0001209191-20-037339-index.htm
2020-05-21Mehdi GasmiDirectorBuy3,599.004.8017,275.20278,041.00https://www.sec.gov/Archives/edgar/data/1501756/000120919120031872/0001209191-20-031872-index.htm
2020-05-18Mehdi GasmiDirectorBuy5,000.004.8024,000.00279,442.00https://www.sec.gov/Archives/edgar/data/1501756/000120919120031047/0001209191-20-031047-index.htm
2020-07-20Mehdi GasmiDirectorBuy5,000.004.8024,000.00279,442.00https://www.sec.gov/Archives/edgar/data/1501756/000120919120043426/0001209191-20-043426-index.htm
2020-06-15Mehdi GasmiDirectorSell5,000.0021.01105,042.00279,442.00https://www.sec.gov/Archives/edgar/data/1501756/000120919120037339/0001209191-20-037339-index.htm
2020-05-05Mehdi GasmiDirectorBuy10,000.004.8048,000.00284,442.00https://www.sec.gov/Archives/edgar/data/1501756/000120919120031047/0001209191-20-031047-index.htm
2020-06-15Mehdi GasmiDirectorBuy10,000.004.8048,000.00284,442.00https://www.sec.gov/Archives/edgar/data/1501756/000120919120037339/0001209191-20-037339-index.htm
2020-06-18Mehdi GasmiDirectorBuy11,127.004.8053,409.60285,569.00https://www.sec.gov/Archives/edgar/data/1501756/000120919120037769/0001209191-20-037769-index.htm
2020-06-22Mehdi GasmiDirectorBuy23,605.004.80113,304.00298,047.00https://www.sec.gov/Archives/edgar/data/1501756/000120919120038635/0001209191-20-038635-index.htm
2020-05-06Mehdi GasmiDirectorBuy25,000.004.80120,000.00299,442.00https://www.sec.gov/Archives/edgar/data/1501756/000120919120031047/0001209191-20-031047-index.htm
2020-02-14James Paul ScopaDirectorBuy10,000.0013.75137,500.0030,000.00https://www.sec.gov/Archives/edgar/data/1501756/000120919120009848/0001209191-20-009848-index.htm
2020-01-15Mehdi GasmiDirectorBuy88,496.00321,418.00https://www.sec.gov/Archives/edgar/data/1501756/000120919120009847/0001209191-20-009847-index.htm
2018-06-15Mehdi GasmiChief Science & Tech OfficerBuy88,496.00387,031.00https://www.sec.gov/Archives/edgar/data/1501756/000120919118038336/0001209191-18-038336-index.htm
2020-05-04James Paul ScopaDirectorBuy23,334.006.48151,204.3253,334.00https://www.sec.gov/Archives/edgar/data/1501756/000120919120027287/0001209191-20-027287-index.htm
2020-08-17Laurent FischerCEO and DirectorBuy7,692.0013.0099,996.007,692.00https://www.sec.gov/Archives/edgar/data/1501756/000120919120047622/0001209191-20-047622-index.htm